Hematopoietic growth factor mimetic small molecule compounds and their uses

US9622991B2 · kind B2 · utility

Assignee

• Ligand Pharmaceuticals Incorporated · US

Inventors

• Lin Zhi · San Diego, US
• Andrew R. Hudson · San Diego, US
• Cornelis Arjan Van Oeveren · Carlsbad, US
• Steven L. Roach · San Diego, US
• Bijan Pedram · San Diego, US
• Yixing Shen · Encinitas, US
• Lino Valdez · Carlsbad, US
• Jillian Basinger · San Diego, US
• Virginia Heather Sharron Grant · San Diego, US
• Jason C. Pickens · San Diego, US

Key dates

• Filing date: May 15, 2015
• Grant date: Apr 18, 2017
• Expiry date: May 15, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D491/113
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present embodiments relate to compounds with physiological effects, such as the activation of hematopoietic growth factor receptors. The present embodiments also relate to use of the compounds to treat a variety of conditions, diseases and ailments such as hematopoietic conditions and disorders.